AISAP Raises $13 Million in Seed Funding for First AI-Powered, Point Of Care Ultrasound Diagnostic Solution
TEL AVIV, Israel, May 2, 2024 /PRNewswire/ -- AISAP, whose AI-powered Point Of Care Assisted Diagnosis (POCAD)™ solution is transforming the medical ultrasound industry, announced its seed funding round today. The company secured $13 million, led by Harel Insurance Investments & Financial Services Ltd. and Shoni Top Ventures, L.P.
- AISAP's POCAD™ solution solves this challenge by providing AI-powered diagnoses that are both highly accurate and easy for any physician to understand – not just ultrasound experts.
- Unlike most other POCUS devices, AISAP's POCAD™ solution can even provide detailed, accurate diagnoses of specific valves within the cardiovascular systems.
- And while the average ultrasound takes weeks on average to provide a full analysis and diagnosis, AISAP's solution does so in as little as 5 minutes.
- In 29% of those cases, the AISAP solution discovered at least one previously-unknown, moderate medical condition.